
Datavant Acquires Aetion to Enhance Real-World Evidence Capabilities
Datavant acquires Aetion to enhance real-world evidence capabilities in healthcare. This merger aims to improve data sharing and analytics. ππ€
Discover the newest research about AI innovations in π§ͺ Drug Discovery.

Datavant acquires Aetion to enhance real-world evidence capabilities in healthcare. This merger aims to improve data sharing and analytics. ππ€

Deep learning enhances sonosensitizer-drug co-assembly, achieving 90% precision and 96% recall for cancer therapy. π‘π¬

Klebsiella pneumoniae’s rising virulence and antibiotic resistance pose significant health risks. π¦ π Explore novel therapeutic strategies!

South Korea’s government supports medtech firms with a new tariff center to address trade challenges. π°π·π

New AI method improves insights into cellular responses to drug treatments. π§¬π Researchers aim to enhance medical research and therapies.

Healthcare AI adoption is rising, with 70% of providers implementing technologies. However, data integration issues remain a challenge. ππ€

BioStruct-Africa’s workshops enhance structural biology skills in Africa, utilizing AI tools like AlphaFold for disease research. ππ¬

Pharmacogenomics enhances drug therapy for rare diseases, optimizing treatment and minimizing adverse reactions. AI tools play a crucial role. π§¬π

New AI Tool Enhances Drug Development for Disease Treatment π§¬π
A new AI tool, LogiRx, accelerates drug development by predicting effects on biological processes, aiding in heart disease treatment.

Recent advancements in materials science are transforming drug delivery systems, enhancing precision medicine. π§¬π Explore nanocarriers, hydrogels, and AI integration.